tm logo
RIVOPHARM
Dead/Cancelled
CANCELLED – SECTION 71

on 19 Jan 2024

Last Applicant/ Owned by

CH-6928 Manno

CH

Serial Number

79195512 filed on 26th Jul 2016

Registration Number

5234473 registered on 04th Jul 2017

in the Principal Register

Correspondent Address

Jeffrey B. Sladkus

Jeffrey B. Sladkus The Sladkus Law Group

Building 6, Suite 200

Atlanta, GA 30339

UNITED STATES

Filing Basis

1. filing basis filed as 66 a

Disclaimer

NO DATA

RIVOPHARM

Pharmaceutical preparations, both prescription and over-the-counter, namely, pharmaceutical preparations for peptic ulcer and gastrooesophageal reflux disease (GORD), propulsives, intestinal anti-infectives, intestinal anti-inflammatory agents, oral pharmaceutical preparations for lowering blood glucose, Vitamin A and D, mixed vitamin preparations consisting of vitamins A and D, vitamin and minera Read More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations, both prescription and over-the-counter, namely, pharmaceutical preparations for peptic ulcer and gastrooesophageal reflux disease (GORD), propulsives, intestinal anti-infectives, intestinal anti-inflammatory agents, oral pharmaceutical preparations for lowering blood glucose, Vitamin A and D, mixed vitamin preparations consisting of vitamins A and D, vitamin and mineral preparations for medical use, vitamin C in the nature of ascorbic acid mixed vitamin preparations consisting partially of Vitamin C, calcium supplements, mineral supplements, anti-thrombotic agents, intravenous solutions, cardiac glycosides, class I and class III anti-arrhythmics, pharmaceutical preparations for cardiac stimulation excluding cardiac glycosides, Vasodilators used in the treatment of cardiac diseases, anti-adrenergic agents, pharmaceutical preparations for acting on arteriolar smooth muscle, Beta blocking agents, Selective calcium channel blockers, pharmaceutical preparations in the nature of Angiotensin Converting Enzyme inhibitors, pharmaceutical preparations in the nature of Angiotensin Converting Enzyme inhibitors combined with other pharmaceutical preparations, anti-fungals for systemic use, anti-infectives and antiseptics, excluding those combined with corticosteroids, oxytocics, plain corticosteroids for systemic use, thyroid preparations, anti-thyroid preparations, tetracyclines preparations, macrolides, lincosamides and streptogramins, aminoglycoside antibacterials, quinolone antibacterials, antimycotics for systemic use, direct acting antivirals, immune sera, bacterial vaccines, alkylating agents, anti-metabolites, plant alkaloids, cytotoxic antibiotics, hormone antagonists and related agents, namely, anti-estrogens, anti-androgens and enzyme inhibitors, immunosuppressive agents, antiinflammatory and antirheumatic preparations, non-steroids in the nature of butylpyrazolidines, acetic acid derivatives, oxicams, propionic acid derivatives, fenamates, Coxibs, muscle relaxants, peripherally acting agents in the nature of curare alkaloids and choline derivatives, antigout preparations, analgesics and antipyretics preparations, anti-migraine preparations, anti-epileptic preparations, anti-cholinergic agents, dopaminergic agents, anti-psychotics, anxiolytics, hypnotics and sedatives, antidepressants, parasympathomimetics, agents for use against amoebiasis and other protozoal diseases, anti-malarial preparation, adrenergics, inhalant anesthetics, adrenergics for systemic use, antihistamines for systemic use, diuretic agents


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 79195512

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

Yes

66A Current

Yes

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
17th Nov 2024TOTAL INVALIDATION PROCESSED BY THE IB
24th Sep 2024TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
24th Sep 2024INVALIDATION PROCESSED
20th Sep 2024TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
19th Jan 2024CANCELLED SECTION 71
04th Jul 2022COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
03rd Nov 2017FINAL DECISION TRANSACTION PROCESSED BY IB
13th Oct 2017NOTIFICATION PROCESSED BY IB
10th Oct 2017FINAL DISPOSITION NOTICE SENT TO IB
10th Oct 2017FINAL DISPOSITION PROCESSED